Thromboembolism Prophylaxis in Adult Patients with Acute Lymphoblastic Leukemia Treated in the GRAALL-2005 Study
Corentin Orvain(Centre Hospitalier Universitaire d'Angers), Mathilde Hunault(Centre National de la Recherche Scientifique), Françoise Rigal‐Huguet(Hôpital Purpan), Véronique Lhéritier(Hospices Civils de Lyon), Marie Balsat(Hôpital Claude Huriez), Jamilé Frayfer, Caroline Bonmati, Sylvain Chantepie(Centre Hospitalier Universitaire de Caen Normandie), Noémie de Gunzburg(Hôpital André Mignot), Patrice Chevallier(Hotel Dieu Hospital), Thomas Pabst(University Hospital of Bern), Victoria Cacheux(Centre Hospitalier Universitaire de Clermont-Ferrand), Denis Caillot, Nicolas Boissel(Inserm), Yves Chalandon(University of Geneva), Norbert H Ifrah(Centre Hospitalier Universitaire d'Angers), Hervé Dombret(University of London Institute in Paris), Jean‐Pierre Marolleau(Centre Hospitalier Universitaire Amiens-Picardie), Emmanuelle Tavernier(Institute Cancer De La Loire Lucien Neuwirth)
Cited by 44
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k